Fisher & Paykel Healthcare Corporation Limited
FSPKF
$20.70
$2.3412.75%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.72% | 11.98% | 10.45% | 9.13% | 7.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.72% | 11.98% | 10.45% | 9.13% | 7.79% |
| Cost of Revenue | 4.47% | 6.43% | 7.74% | 7.01% | 6.28% |
| Gross Profit | 18.24% | 15.71% | 12.28% | 10.58% | 8.83% |
| SG&A Expenses | 5.49% | 7.95% | 9.74% | 10.59% | 11.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.81% | 7.76% | 9.03% | 8.88% | 8.76% |
| Operating Income | 39.90% | 28.14% | 15.75% | 10.07% | 4.16% |
| Income Before Tax | 106.80% | 33.15% | -15.82% | -22.61% | -29.52% |
| Income Tax Expenses | 18.70% | 25.19% | 31.36% | 30.64% | 30.30% |
| Earnings from Continuing Operations | 175.11% | 37.08% | -32.52% | -40.33% | -48.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 175.11% | 37.08% | -32.52% | -40.33% | -48.02% |
| EBIT | 39.90% | 28.14% | 15.75% | 10.07% | 4.16% |
| EBITDA | 35.87% | 27.35% | 17.87% | 12.19% | 6.27% |
| EPS Basic | 173.03% | 35.84% | -33.11% | -40.78% | -48.29% |
| Normalized Basic EPS | 45.31% | 27.80% | 10.69% | 4.98% | -0.91% |
| EPS Diluted | 172.83% | 35.58% | -33.33% | -40.86% | -48.30% |
| Normalized Diluted EPS | 45.18% | 27.69% | 10.54% | 4.83% | -1.05% |
| Average Basic Shares Outstanding | 0.61% | 0.69% | 0.77% | 0.72% | 0.66% |
| Average Diluted Shares Outstanding | 0.69% | 0.77% | 0.85% | 0.82% | 0.78% |
| Dividend Per Share | -0.59% | 0.79% | 1.43% | 0.84% | 0.24% |
| Payout Ratio | -0.50% | -0.17% | 0.39% | 0.33% | 0.31% |